Flagyl · DIN 01926853 · 500 mg · capsule
Listed, not a benefit; Health Canada lists this DIN as Cancelled pre market since 2024-05-15 — choose a marketed DIN from the same-category list.Discontinued May 15, 2024 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled pre market since 2024-05-15 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record (an EAP request with clinical rationale is still possible); see alternatives; Health Canada lists this DIN as Cancelled pre market since 2024-05-15 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Flagyl · DIN 01926853
Manufacturer: Sanofi-Aventis Canada Inc.; listing date 1996-10-01
Daily cost (source): $0.8217
Health Canada: Cancelled pre market since 2024-05-15 · brand FLAGYL · ATC P01AB01 METRONIDAZOLE · form Capsule · route Oral · ingredients METRONIDAZOLE 500 MG · company Sanofi-aventis canada inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordFlagyl: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01926853)
Source record
DIN 01926853: Flagyl
Raw flags: notABenefit=Y, sec3=Y
Item: 083200002; group id 125; item number 0209; lccId None; manufacturer id SAC
Source form: Cap; strength: 500mg
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01926853
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12221
Interchangeable products
Apo-Metronidazole · DIN 02248562 · $0.2739
Auro-Metronidazole · DIN 02470284 · $0.2739
M-Metronidazole · DIN 02519755 · $0.2739
Metronidazole · DIN 02518767 · $0.2739
Metronidazole · DIN 02534592 · $0.2739
PMS-Metronidazole · DIN 00783137 · $0.2739
Shortage status: discontinued (January 31, 2023, reported by ODAN LABORATORIES LTD); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01926853
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled pre market since May 15, 2024 — choose a marketed DIN from the same-category list.